openPR Logo
Press release

๏ปฟAnti-Obesity Drugs Market Estimated to Reach US$ 5.95 Billion by 2030 | Rapid Growth Projected

Anti-Obesity Drugs Market

Anti-Obesity Drugs Market

Forecast Increase in Revenue:

Anti-Obesity Drugs Market is expected to reach US$ 5.95 Bn by 2030 from US$ 2.22 Bn in 2023, at a CAGR of 15.1% during the forecast period.

Anti-Obesity Drugs Market Overview:

The Anti-Obesity Drugs Market is driven by the global rise in obesity rates and the need for effective weight management solutions. These medications help reduce body weight by altering appetite or calorie intake, addressing a growing health crisis exacerbated by sedentary lifestyles and poor eating habits. With the World Health Organization's data highlighting significant numbers of overweight adults, major pharmaceutical players are intensifying their efforts to develop and gain approval for new anti-obesity treatments. The market is shaped by innovations in drug development, increasing healthcare awareness, and emerging regional opportunities.

๐˜๐จ๐ฎ๐ซ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ˆ๐ฌ ๐‰๐ฎ๐ฌ๐ญ ๐š ๐‚๐ฅ๐ข๐œ๐ค ๐€๐ฐ๐š๐ฒ: https://www.maximizemarketresearch.com/request-sample/100768/

Drivers in the Anti-Obesity Drugs Market:

The primary driver of the Anti-Obesity Drugs Market is the escalating prevalence of obesity and overweight conditions worldwide. As unhealthy lifestyles and dietary habits contribute to rising obesity rates, the demand for effective pharmacological solutions increases. The growing global obesity epidemic, alongside a surge in type II diabetes cases, propels the need for novel anti-obesity treatments, stimulating market growth and encouraging pharmaceutical companies to expand their research and development efforts.

Anti-Obesity Drugs Market Trends:

Key trends in the Anti-Obesity Drugs Market include a shift towards drugs with long-term efficacy and dual benefits for obesity and related metabolic disorders, such as type II diabetes. Innovations in drug mechanisms and collaborations between major pharmaceutical companies are leading to the development of new therapies. Additionally, increasing consumer awareness and preference for prescription-based anti-obesity treatments are shaping the market landscape, reflecting a growing emphasis on addressing obesity through medically supervised interventions.

๐‚๐ฅ๐ข๐œ๐ค ๐‡๐ž๐ซ๐ž ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ฒ ๐…๐จ๐ซ ๐Œ๐จ๐ซ๐ž ๐ƒ๐ž๐ญ๐š๐ข๐ฅ๐ฌ: https://www.maximizemarketresearch.com/inquiry-before-buying/100768/

Anti-Obesity Drugs Market Opportunities:

The Anti-Obesity Drugs Market presents significant opportunities due to the rising demand for effective long-term obesity treatments and the expansion into emerging markets. The development of new drugs and combination therapies, as well as strategic alliances and collaborations among key industry players, are expected to drive market growth. Emerging regions with rising disposable incomes and increasing healthcare expenditures offer untapped potential for market expansion, making them key targets for future development and investment.

What is Anti-Obesity Drugs Market Regional Insight?

North America is poised to dominate the Anti-Obesity Drugs Market due to high obesity rates and substantial healthcare spending. Meanwhile, the Asia-Pacific region is anticipated to experience the highest growth, driven by rising disposable incomes, increasing healthcare investments, and growing awareness of obesity management. Countries like India, China, and South Korea are particularly notable for their expanding anti-obesity drug markets, fueled by both rising obesity rates and the growing demand for effective weight management solutions.

๐‚๐ฅ๐ข๐œ๐ค ๐ก๐ž๐ซ๐ž ๐Ÿ๐จ๐ซ ๐Ÿ๐ซ๐ž๐ž ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž + ๐ซ๐ž๐ฅ๐š๐ญ๐ž๐ ๐ ๐ซ๐š๐ฉ๐ก๐ฌ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ: https://www.maximizemarketresearch.com/request-sample/100768/

Segmentation Analysis of the Anti-Obesity Drugs Market:

by Mechanism of Action

Peripherally Acting Drugs
Centrally Acting Drugs

by Drug Type

Prescription Drugs
OTC Drugs

by Distribution Channel

Hospitals Pharmacies
Retail Pharmacies
E-commerce

Who is the largest manufacturers of Anti-Obesity Drugs Market worldwide?

North America
1. Icahn Enterprises
2. Pfizer
3. Orexigen Therapeutics
4. Bristol-Myers Squibb

Europe
5. Novo Nordisk
6. Roche
7. Norgine
8. GSK
9. Saniona
10. AstraZeneca
11. Hikma Pharmaceuticals

APAC
12. Eisai
13. Takeda Pharmaceutical Company
14. Sanofi India
15. Sun Pharmaceutical Industries
16. Teijin Pharma
17. Kowa
18. Cipla
19. Torrent Pharmaceuticals
20. Zydus Lifesciences
21. Glenmark Pharmaceuticals

Middle East
22. Teva Pharmaceutical Industries
23. Gulf Pharmaceutical Industries
24. Saudi Pharmaceutical Industries & Medical Appliances
25. The Jordanian Pharmaceutical Manufacturing Company

South America
26. Eurofarma Laboratorios

๐…๐จ๐ซ ๐ฆ๐จ๐ซ๐ž ๐ข๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง ๐š๐›๐จ๐ฎ๐ญ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐ฏ๐ข๐ฌ๐ข๐ญ: https://www.maximizemarketresearch.com/market-report/global-anti-obesity-drugs-market/100768/

Key Offerings:

Past Market Size and Competitive Landscape
Anti-Obesity Drugs Market Size, Share, Size & Forecast by different segment
Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by region
Anti-Obesity Drugs Market Segmentation - A detailed analysis by Product
Competitive Landscape - Profiles of selected key players by region from a strategic perspective
Competitive landscape - Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER's analysis
Value chain and supply chain analysis
Legal Aspects of business by region
Lucrative business opportunities with SWOT analysis
Recommendations

For additional reports on related topics, visit our website:

โ™ฆ Healthcare IT outsourcing market: https://www.maximizemarketresearch.com/market-report/healthcare-it-outsourcing-market/53698/

โ™ฆ Global Tank Container Market: https://www.maximizemarketresearch.com/market-report/global-tank-container-market/83753/

โ™ฆ Shingles Vaccine Market: https://www.maximizemarketresearch.com/market-report/shingles-vaccine-market/124937/

โ™ฆ global lamp shades market: https://www.maximizemarketresearch.com/market-report/global-lamp-shades-market/68520/

โ™ฆ Global Spatial Genomics & Transcriptomics Market: https://www.maximizemarketresearch.com/market-report/global-spatial-genomics-transcriptomics-market/115015/

โ™ฆ Oil Shale Market: https://www.maximizemarketresearch.com/market-report/global-oil-shale-market/22535/

โ™ฆ Electric Blankets Market: https://www.maximizemarketresearch.com/market-report/global-electric-blankets-market/37912/

โ™ฆ Global Automotive Leaf Spring Market: https://www.maximizemarketresearch.com/market-report/global-automotive-leaf-spring-market/21179/

โ™ฆ Global Meat Processing Equipment Market: https://www.maximizemarketresearch.com/market-report/global-meat-processing-equipment-market/27045/

โ™ฆ Global Enterprise Content Management Market: https://www.maximizemarketresearch.com/market-report/global-enterprise-content-management-market/6974/

Contact Maximize Market Research:

MAXIMIZE MARKET RESEARCH PVT. LTD.
โฎ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
โœ† +91 9607365656
๐Ÿ–‚ sales@maximizemarketresearch.com
๐ŸŒ www.maximizemarketresearch.com

About Maximize Market Research:

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release ๏ปฟAnti-Obesity Drugs Market Estimated to Reach US$ 5.95 Billion by 2030 | Rapid Growth Projected here

News-ID: 3636457 • Views: โ€ฆ

More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD

Global Plasma Fractionation Market Valued at $30.84 Billion in 2023, Projected to Grow at 6.89% CAGR
Global Plasma Fractionation Market Valued at $30.84 Billion in 2023, Projected t โ€ฆ
๐†๐ฅ๐จ๐›๐š๐ฅ ๐๐ฅ๐š๐ฌ๐ฆ๐š ๐…๐ซ๐š๐œ๐ญ๐ข๐จ๐ง๐š๐ญ๐ข๐จ๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ The Global Plasma Fractionation Market is witnessing a rapid evolution driven by technological advancements and shifting consumer demands. As businesses navigate this dynamic landscape, our overview acts as a valuable resource to make informed decisions and capitalize on emerging opportunities. ๐€๐ฏ๐š๐ข๐ฅ๐š๐›๐ฅ๐ž ๐„๐ฑ๐œ๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.maximizemarketresearch.com/request-sample/6677/ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐„๐ฌ๐ญ๐ข๐ฆ๐š๐ญ๐ž: Global Plasma Fractionation Market was valued at USD 30.84 Bn. in 2023. Global Plasma Fractionation Market size isโ€ฆ
Global Industry 4.0 Market Projected to Reach $367.50 Billion by 2030, Growing at 20.7% CAGR
Global Industry 4.0 Market Projected to Reach $367.50 Billion by 2030, Growing a โ€ฆ
๐†๐ฅ๐จ๐›๐š๐ฅ ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐Ÿ’ ๐ŸŽ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ The Global Industry 4 0 Market is witnessing a rapid evolution driven by technological advancements and shifting consumer demands. As businesses navigate this dynamic landscape, our overview acts as a valuable resource to make informed decisions and capitalize on emerging opportunities. ๐€๐ฏ๐š๐ข๐ฅ๐š๐›๐ฅ๐ž ๐„๐ฑ๐œ๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.maximizemarketresearch.com/request-sample/35222/ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐„๐ฌ๐ญ๐ข๐ฆ๐š๐ญ๐ž: Global Industry 4.0 Market size was valued at USD 98.47 Bn in 2023 and is expectedโ€ฆ
Genome Editing Market Expected to Reach $20.19 Billion by 2030, Growing at 15.8% CAGR
Genome Editing Market Expected to Reach $20.19 Billion by 2030, Growing at 15.8% โ€ฆ
๐†๐ž๐ง๐จ๐ฆ๐ž ๐„๐๐ข๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ The Genome Editing Market is witnessing a rapid evolution driven by technological advancements and shifting consumer demands. As businesses navigate this dynamic landscape, our overview acts as a valuable resource to make informed decisions and capitalize on emerging opportunities. ๐€๐ฏ๐š๐ข๐ฅ๐š๐›๐ฅ๐ž ๐„๐ฑ๐œ๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.maximizemarketresearch.com/request-sample/2747/ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐„๐ฌ๐ญ๐ข๐ฆ๐š๐ญ๐ž: The Genome Editing Market size was valued at USD 7.23 Bn in 2023 and market revenue is growing at aโ€ฆ
Aesthetics Injectables Market to Reach $25.55 Billion by 2030, Growing at 12.80% CAGR
Aesthetics Injectables Market to Reach $25.55 Billion by 2030, Growing at 12.80% โ€ฆ
๐€๐ž๐ฌ๐ญ๐ก๐ž๐ญ๐ข๐œ๐ฌ ๐ˆ๐ง๐ฃ๐ž๐œ๐ญ๐š๐›๐ฅ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ The Aesthetics Injectables Market is witnessing a rapid evolution driven by technological advancements and shifting consumer demands. As businesses navigate this dynamic landscape, our overview acts as a valuable resource to make informed decisions and capitalize on emerging opportunities. ๐€๐ฏ๐š๐ข๐ฅ๐š๐›๐ฅ๐ž ๐„๐ฑ๐œ๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.maximizemarketresearch.com/request-sample/149511/ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐„๐ฌ๐ญ๐ข๐ฆ๐š๐ญ๐ž: Aesthetics Injectables Market size was valued at USD 11.36 Billion in 2023 and the Aesthetics Injectables Market revenue is expectedโ€ฆ

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application โ€ฆ
Market Study Report, LLC, has compiled an exhaustive research study of the โ€˜Alcohol Testing And Drug Testing Equipment marketโ€™, detailing every single market driver and intricately analyzing the business vertical. This โ€˜Alcohol Testing And Drug Testing Equipment marketโ€™ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drugโ€ฆ
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drugย Marketย From an insight perspective, the market report focuses on various levels of analyses โ€” industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.ย  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetesโ€ฆ
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymeraseโ€ฆ
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals โ€ฆ
AstraZenecaโ€™s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devicโ€™s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioningโ€ฆ
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and โ€ฆ
This yearโ€™s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drugโ€ฆ